Chenxi Li
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
-
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 detection and testing 1
-
- Angiogenesis and VEGF in Cancer 1
- Co-authors
- Bo Tang (1 shared paper)Yunfeng Wang (1 shared paper)Bing Gu (1 shared paper)Haiquan Kang (1 shared paper)Wensen Chen (1 shared paper)Kai Zhang (1 shared paper)Zhihong Ye (1 shared paper)Chen Chen (1 shared paper)
- Journals
- Clinica Chimica Acta (2 papers)Medicine (2 papers)Frontiers in Immunology (2 papers)Hypertension in Pregnancy (1 paper)Archives of Gerontology and Geriatrics (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Chenxi Li
10 papers receiving 303 citations
Peers
Comparison fields: 5 of 77
- Infectious Diseases 126
- Neurology 39
- Aging 5
- Obstetrics and Gynecology 15
- Radiology, Nuclear Medicine and Imaging 41
Countries citing papers authored by Chenxi Li
This map shows the geographic impact of Chenxi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenxi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenxi Li more than expected).
Fields of papers citing papers by Chenxi Li
This network shows the impact of papers produced by Chenxi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenxi Li. The network helps show where Chenxi Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenxi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 97 | |
| 2 | 2020 | 90 | |
| 3 | 2023 | 38 | |
| 4 | 2021 | 36 | |
| 5 | 2024 | 15 | |
| 6 | 2020 | 15 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 5 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 1 |
About Chenxi Li
Chenxi Li is a scholar working on Infectious Diseases, Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 10 papers that have together received 310 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Cancer Mechanisms and Therapy (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Ferroptosis and cancer prognosis (1 paper), SARS-CoV-2 detection and testing (1 paper), Infective Endocarditis Diagnosis and Management (1 paper), Pain Mechanisms and Treatments (1 paper) and Immune cells in cancer (1 paper). The work is most often cited by research in Infectious Diseases (126 citations), Neurology (39 citations), Aging (5 citations), Obstetrics and Gynecology (15 citations) and Radiology, Nuclear Medicine and Imaging (41 citations). Chenxi Li has collaborated with scholars based in China and United States. Frequent co-authors include Bo Tang, Yunfeng Wang, Bing Gu, Haiquan Kang, Wensen Chen, Kai Zhang, Zhihong Ye, Chen Chen, Xingqi Cao and Zuyun Liu. Their work appears in journals such as Clinica Chimica Acta, Medicine, Frontiers in Immunology, Hypertension in Pregnancy and Archives of Gerontology and Geriatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.